Free Trial
NASDAQ:ADXS

Ayala Pharmaceuticals (ADXS) Stock Price, News & Analysis

Ayala Pharmaceuticals logo
$0.12 +0.09 (+261.26%)
As of 07/2/2025 11:38 AM Eastern

About Ayala Pharmaceuticals Stock (NASDAQ:ADXS)

Key Stats

Today's Range
$0.12
$0.12
50-Day Range
$0.03
$0.12
52-Week Range
$0.00
$0.78
Volume
195 shs
Average Volume
5,773 shs
Market Capitalization
$5.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ADXS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ayala Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ADXS Stock News Headlines

Ayala Pharmaceuticals, Inc. (ADXS) - Yahoo Finance
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
Ayala unit expands cold storage network
Immunome: An Oncology Powerhouse In The Making
See More Headlines

ADXS Stock Analysis - Frequently Asked Questions

Ayala Pharmaceuticals' stock was trading at $0.0270 at the beginning of the year. Since then, ADXS shares have increased by 345.6% and is now trading at $0.1203.
View the best growth stocks for 2025 here
.

Ayala Pharmaceuticals, Inc. (NASDAQ:ADXS) issued its quarterly earnings results on Thursday, September, 9th. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.04) by $0.02. The business had revenue of $0.25 million for the quarter.

Shares of ADXS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ayala Pharmaceuticals investors own include Inovio Pharmaceuticals (INO), Onconova Therapeutics (ONTX), Madrigal Pharmaceuticals (MDGL), Merck & Co., Inc. (MRK), Acasti Pharma (ACST), Bristol Myers Squibb (BMY) and

Company Calendar

Last Earnings
9/09/2021
Today
7/03/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ADXS
Employees
20
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$3.24 million
Price / Cash Flow
N/A
Book Value
($2.06) per share
Price / Book
-0.06

Miscellaneous

Free Float
42,364,000
Market Cap
$5.13 million
Optionable
Not Optionable
Beta
1.18
10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:ADXS) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners